Nephrology Condition Center Quiz

Question Title

1. Name (Required.)

Question Title

2. Email Address (Required.)

Question Title

3. Approximately what percentage of US adults are estimated to have chronic kidney disease (CKD)? (Required.)

10%

15%

25%

Question Title

4. After initiating dialysis, phosphorus levels commonly begin to rise within which timeframe if not adequately controlled? (Required.)

1-3 moths

6-9 months

12 months

Only in late-stage dialysis

Question Title

5. Approximately what proportion of patients on dialysis experience hyperphosphatemia at some point during treatment? (Required.)

25%

40%

60%

>80%

Question Title

6. Approximately what percentage of patients prescribed phosphate binders are estimated to be nonadherent? (Required.)

20%

35%

50%

75%

Question Title

7. Which counseling point is most important for primary care physicians when reinforcing phosphate binder use in dialysis patients? (Required.)

Binders should be taken at bedtime

Binders are only needed on dialysis days

Binders should be taken with meals to bind dietary phosphate

Binders replace dietary phosphate restriction

Question Title

8. Which factor most commonly contributes to phosphate binder discontinuation or inconsistent use? (Required.)

Cost alone

Pill burden and GI tolerability

Lack of efficacy

Drug–drug interactions

Nephrology Condition Center Quiz

Question Title

* 1. Name (Required.)

Question Title

* 2. Email Address (Required.)

Question Title

* 3. Approximately what percentage of US adults are estimated to have chronic kidney disease (CKD)? (Required.)

Question Title

* 4. After initiating dialysis, phosphorus levels commonly begin to rise within which timeframe if not adequately controlled? (Required.)

Question Title

* 5. Approximately what proportion of patients on dialysis experience hyperphosphatemia at some point during treatment? (Required.)

Question Title

* 6. Approximately what percentage of patients prescribed phosphate binders are estimated to be nonadherent? (Required.)

Question Title

* 7. Which counseling point is most important for primary care physicians when reinforcing phosphate binder use in dialysis patients? (Required.)

Question Title

* 8. Which factor most commonly contributes to phosphate binder discontinuation or inconsistent use? (Required.)

1. Name (Required.)

2. Email Address (Required.)

3. Approximately what percentage of US adults are estimated to have chronic kidney disease (CKD)? (Required.)

4. After initiating dialysis, phosphorus levels commonly begin to rise within which timeframe if not adequately controlled? (Required.)

5. Approximately what proportion of patients on dialysis experience hyperphosphatemia at some point during treatment? (Required.)

6. Approximately what percentage of patients prescribed phosphate binders are estimated to be nonadherent? (Required.)

7. Which counseling point is most important for primary care physicians when reinforcing phosphate binder use in dialysis patients? (Required.)

8. Which factor most commonly contributes to phosphate binder discontinuation or inconsistent use? (Required.)